Dr. Talan received his medical degree from the University of Illinois Medical College in Chicago. He completed his residencies in Internal and Emergency Medicine and fellowship in Infectious Diseases at the University of California Los Angeles (UCLA) and its associated medical centers. He is board certified in Internal Medicine, Emergency Medicine, and Infectious Diseases.
From 1993 to 2014, Dr. Talan was Chairman of the Olive View-UCLA Department of Emergency Medicine. He is currently faculty of the Department of Emergency Medicine, and Department of Medicine, Division of Infectious Diseases at Olive View-UCLA Medical Center. He is Professor of Medicine in Residence (Emeritus) at The David Geffen School of Medicine at UCLA. He is a Fellow of the American College of Emergency Physicians and the Infectious Diseases Society of America. Dr. Talan serves on the editorial boards of the Annals of Emergency Medicine and Emergency Medicine News and is a reviewer for many journals including Clinical Infectious Diseases, JAMA, and The Medical Letter.
Dr. Talan is considered an authority in the area of acute infections that result in severe morbidity and death. His research focuses on emergency department-based surveillance and epidemiological research of emerging infections and clinical investigations of acute infectious diseases. He has investigated skin and soft tissue infections, animal and human bites, rabies, tetanus, pneumonia, pyelonephritis, meningitis, and sepsis. Dr. Talan has several publications in JAMA and the New England Journal of Medicine, including the seminal research on the emergence of community associated-MRSA in patients with skin and soft tissue infections. He edited and authored the Infectious Diseases Clinics of North America edition on infectious disease emergences. He is principal investigator of a CDC-supported emergency department-based national sentinel network for research on emerging infectious diseases in the United States called EMERGEncy ID NET, which has been in existence since 1995. He was principal investigator of a recently completed NIH contract to study off-patent antibiotics to treat skin and soft tissue infections caused by community-associated MRSA called STOP MRSA. He is currently principal investigator of an NIH R21 grant to study non-operative management of acute uncomplicated appendicitis. Dr. Talan has been invited to lecture nationally and internationally on infectious disease emergencies and emergency department surveillance and research.